TON - February 2011 Vol 4, No 1

TON - February 2011 Vol 4, No 1 — February 16, 2011

SAN DIEGO—Prostate cancer patients who are treated with a combination of androgen deprivation therapy (ADT) and radiotherapy may have a substantially improved chance of survival compared with patients who do not receive radiotherapy, according to British researchers. They reported at the 52nd annual meeting of the American Society for Radiation Oncology that combination therapy resulted in substantial benefits in overall survival and disease-specific survival in men with locally advanced prostate cancer.

Read More ›

TON - February 2011 Vol 4, No 1 — February 16, 2011

I discovered my tumor by accident, shortly after taking custody of my two granddaughters. I was playing on the floor with them when one straddled my stomach and plopped down. The pain was unbelievable; I knew there was something very wrong. The many tests that followed were inconclusive, and my doctors thought it was a growth in my uterus so I was scheduled for a hysterectomy.

Read More ›

TON - February 2011 Vol 4, No 1 — February 16, 2011

Cancer-related pain does not stop after the initial treatment period for almost 20% of survivors. In a first-of-its-kind study, researchers also found racial, in this study blacks, and sex, in this study women, disparities in cancer-related chronic pain.

Read More ›

TON - February 2011 Vol 4, No 1 — February 16, 2011

Patient navigators facilitated almost 700 cancer screenings among Latino Medicare beneficiaries through a cancer prevention and treatment demonstration project for ethnic and racial minorities at the University of Medicine and Dentistry of New Jersey (UMDNJ). The project seeks to address disparities in cancer screening rates in the elderly Latino population in the Newark, New Jersey, area. The project also is evaluating the impact of navigators to facilitate that screening.

Read More ›

TON - February 2011 Vol 4, No 1 — February 16, 2011

Multiple myeloma (MM) is a disease with variable presentation, disease trajectory, prognosis, and options for treatment. Integrating the plethora of scientific discovery relative to plasma cell disorders, molecular and cytogenetic attributes and their implications for prognosis and treatment, identification of key components of the bone marrow micro - environment, and the development of novel therapies targeting many of these attributes requires a thorough review of multiple sources of information. Multiple Myeloma: A Textbook for Nurses, edited by Joseph D. Read More ›


TON - February 2011 Vol 4, No 1 — February 16, 2011
Today, plastic surgery has achieved great strides in restoring appearance and function.1 In patients with cancer, reconstructive surgery must allow for adequate resection of tumor with clear margins, facilitate initiation of adjuvant therapy, and maximize quality of life by making the most of function and esthetics. Read More ›

ORLANDO—A study of physicians from five countries found that nurses and hematologists counseling patients with chronic myeloid leukemia about the importance of adherence to prescribed tyrosine kinase inhibitors (TKIs) or having an established adherence protocol, such as medication diaries, pill organizers, or informational calendars, was associated with improved adherence, and those patients who took the drugs as prescribed had significantly better therapeutic milestones. Read More ›

TON - February 2011 Vol 4, No 1 — December 23, 2010
SAN ANTONIO—Researchers are reporting “woefully inadequate” mammography rates in American women, even in those with healthcare coverage.  Read More ›

Page 2 of 2


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: